Why Is Combination Laser Therapy Recommended For Treating Acquired Bilateral Nevus Of Ota-Like Macules (Hori's Macules), And How Do Multi-Device Protocols Enhance Outcomes?

Combination laser therapy is recommended for Hori’s macules because the condition involves dermal melanocytes at more than one depth. A single wavelength may not reach or effectively fragment all pigment, producing incomplete clearance and potentially increasing the risk of post-inflammatory hyperpigmentation (PIH). Multi-device protocols combine different penetration depths or use epidermal resurfacing to improve access to the dermal pigment while controlling treatment intensity.

The central advantage of combination therapy is depth matching: different lasers address pigment in different anatomical layers, while carefully staged treatment can improve clearance without requiring excessive energy from one device.

Why Hori’s Macules Are Difficult to Treat

The Pigment Lies in the Dermis

Hori’s macules, also called Acquired Bilateral Nevus of Ota-like Macules (ABNOM), are characterized by melanocytes distributed through the papillary and middle dermis.

This depth distinguishes them from purely epidermal pigmentation. Treatment therefore requires laser energy capable of reaching dermal pigment while preserving surrounding tissue.

Pigment Depth Is Not Uniform

Although the lesions share a characteristic distribution, the exact depth and density of melanocytes can vary between patients and even between facial areas.

A single wavelength may therefore work well for some pigment but less effectively for pigment located deeper or more superficially.

Clearance Must Be Balanced Against Inflammation

Q-switched lasers fragment melanin-containing structures through selective photothermolysis. However, excessive fluence, repeated passes, or aggressive treatment can increase inflammation and contribute to PIH, particularly in patients with more reactive or darker skin types.

The clinical challenge is not simply to deliver more energy. It is to deliver effective energy at the appropriate depth with the least unnecessary tissue injury.

How Multi-Device Protocols Improve Outcomes

Combining 532 nm and 1064 nm Nd:YAG Lasers

A Q-switched 532 nm Nd:YAG laser is absorbed more superficially, while a Q-switched 1064 nm Nd:YAG laser penetrates more deeply.

Using both wavelengths allows treatment to address pigment across the dermal depth range rather than relying on one wavelength to manage every component. This can produce more complete pigment fragmentation than single-wavelength treatment.

Matching Wavelength to Pigment Depth

The shorter wavelength can target relatively superficial pigment, while the longer wavelength can reach pigment in the deeper dermis.

This depth-specific approach is analogous to using different tools for shallow and deep deposits: each device contributes where its physical properties are most useful.

Improving Overall Clearance

When pigment is distributed across more than one layer, treating only one depth can leave residual macules or require repeated sessions.

A coordinated two-wavelength protocol can increase the proportion of pigment treated during each treatment course, improving clinical clearance compared with monotherapy in appropriately selected patients.

Using Ablative Resurfacing Before a Q-Switched Laser

Another strategy is to use an ablative Er:YAG or CO2 laser to remove the superficial epidermal layer before applying a Q-switched pigment laser, such as a ruby laser.

Because the epidermis can attenuate or scatter some of the incoming energy, removing this superficial barrier may allow subsequent laser passes to penetrate more effectively toward the dermal melanocytes.

Reducing the Need for Excessive Pigment-Laser Energy

Improved access to the dermis may allow the clinician to achieve stronger pigment targeting without relying solely on progressively higher energy from the Q-switched device.

That may help balance efficacy with the risk of inflammation and PIH, although the ablative step itself introduces additional healing requirements and must be selected carefully.

Why Single-Laser Treatment May Be Inconsistent

One Wavelength Has a Limited Depth Profile

Every laser wavelength has characteristic absorption and penetration behavior. A single device may be highly effective for one component of the lesion but less effective for pigment at another depth.

Residual pigment can then make the response appear uneven or incomplete.

Incomplete Clearance Can Require Repeated Treatment

When treatment does not adequately address the full dermal distribution, additional sessions may be needed.

Repeated treatment is not inherently inappropriate, but ongoing inflammation from poorly matched or overly aggressive protocols can increase the risk of unwanted pigmentation.

Higher Energy Is Not a Universal Solution

Increasing fluence to compensate for inadequate depth targeting can damage surrounding tissue without proportionally improving pigment clearance.

Combination therapy changes the treatment strategy from “more energy from one device” to better distribution of energy across the relevant depths.

Understanding the Trade-offs

Combination Therapy Is More Technically Demanding

Multi-device treatment requires careful sequencing, wavelength selection, fluence adjustment, and assessment of the patient’s skin response.

The protocol should be individualized rather than applied as a fixed recipe. A combination that is appropriate for one lesion depth or skin type may be excessive for another.

Ablative Pretreatment Adds Recovery

Er:YAG and CO2 resurfacing can improve access to deeper targets, but they also create a controlled epidermal injury.

Patients may experience more downtime, redness, crusting, or barrier disruption than with non-ablative pigment treatment. Appropriate wound care and strict photoprotection are essential.

PIH Risk Is Reduced, Not Eliminated

Combination protocols may reduce the need for aggressive single-wavelength treatment, but they do not remove the risk of PIH.

Inflammation, recent sun exposure, inadequate sun protection, inappropriate settings, and individual pigmentary reactivity can all affect the outcome.

Not Every “Combination” Is Evidence-Based for Hori’s Macules

Different lasers should be combined only when their roles are anatomically and physiologically justified.

Protocols designed for other conditions, such as melanocytic nevi, hypertrichosis, or melasma, should not be transferred automatically to Hori’s macules. The treatment plan must remain focused on the dermal melanocyte distribution characteristic of ABNOM.

Diagnosis Must Be Confirmed

Blue-gray or brown facial macules can have several causes, and visually similar disorders may respond differently to laser treatment.

A qualified clinician should confirm the diagnosis and assess factors such as skin type, lesion depth, previous treatment, active inflammation, and PIH history before selecting a protocol.

How to Apply This to Treatment Planning

The most appropriate protocol depends on pigment depth, skin reactivity, prior treatment response, and the patient’s tolerance for downtime.

If your primary focus is maximum pigment clearance: Consider a depth-matched protocol using QS 532 nm and QS 1064 nm Nd:YAG wavelengths when clinically appropriate, because the two wavelengths can address relatively superficial and deeper dermal pigment components.
If your primary focus is improving access to deeper dermal pigment: An ablative Er:YAG or CO2 pretreatment followed by a suitable Q-switched laser may improve penetration, provided the patient accepts the additional recovery period.
If your primary focus is minimizing PIH risk: Favor conservative, individualized settings, careful staging, strict photoprotection, and avoidance of unnecessary passes or energy escalation.
If your primary focus is managing a treatment-resistant or previously treated lesion: Reassess the diagnosis, pigment depth, and prior laser parameters before adding devices, rather than assuming that more aggressive treatment will produce better clearance.

The strongest rationale for combination laser therapy is precise treatment of pigment at different depths while maintaining control over inflammation and recovery.

Summary Table:

Strategy	How It Helps	Key Considerations
QS 532 nm + QS 1064 nm Nd:YAG	Targets superficial and deep dermal pigment	Depth matching; individualized fluence
Ablative resurfacing + Q-switched laser	Removes epidermal barrier for better penetration	Increased downtime; proper wound care
Conservative settings & staging	Minimizes inflammation and PIH	Strict photoprotection; tailored to skin type
Reassessment for resistant lesions	Confirms diagnosis and prior parameters	Avoids unnecessary aggressive treatment

Upgrade your clinic's aesthetic capabilities with BELIS's advanced laser platforms. Our Q-switched Nd:YAG, Er:YAG, and CO2 systems are engineered for precision and safety, helping you achieve superior outcomes for Hori's macules and other pigmented lesions. Partner with us for reliable supply, certifications, and OEM/ODM support. Contact us today to learn how BELIS can elevate your practice.